BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 11454253)

  • 1. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
    You EY; Kang TJ; Kim SK; Lee SB; Chae GT
    J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone resistance in Mycobacterium leprae.
    Gillis TP; Williams DL
    Lepr Rev; 2000 Dec; 71 Suppl():S91-5. PubMed ID: 11201896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
    Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
    Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A drug-resistant leprosy case detected by DNA sequence analysis from a relapsed Mexican leprosy patient.
    Lopez-Roa RI; Fafutis-Morris M; Masanori M
    Rev Latinoam Microbiol; 2006; 48(3-4):256-9. PubMed ID: 18293659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance.
    Nakata N; Kai M; Makino M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):762-6. PubMed ID: 21115799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
    Matsuoka M; Suzuki Y; Garcia IE; Fafutis-Morris M; Vargas-González A; Carreño-Martinez C; Fukushima Y; Nakajima C
    Jpn J Infect Dis; 2010 Nov; 63(6):412-6. PubMed ID: 21099091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1.
    Nisha J; Ramanathan K; Nawaz Khan F; Dhanasekaran D; Shanthi V
    Mol Biosyst; 2016 Jun; 12(7):2178-88. PubMed ID: 27120972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of rifampin and dapsone resistance in three patients with recurring leprosy].
    Hernández E; Cardona-Castro N; Rodríguez G; Villegas S; Beltrán C; Kimura M; Vissa VD; Gómez Y
    Rev Panam Salud Publica; 2008 Feb; 23(2):73-7. PubMed ID: 18371276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
    Beltrán-Alzate C; López Díaz F; Romero-Montoya M; Sakamuri R; Li W; Kimura M; Brennan P; Cardona-Castro N
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005041. PubMed ID: 27706165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012.
    Williams DL; Araujo S; Stryjewska BM; Scollard D
    Emerg Infect Dis; 2018 Aug; 24(8):1584-1585. PubMed ID: 30016255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 18. Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
    Li W; Sakamuri RM; Lyons DE; Orcullo FM; Shinde V; Dela Pena EL; Maghanoy AA; Mallari IB; Tan EV; Nath I; Brennan PJ; Balagon M; Vissa V
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5384-7. PubMed ID: 21859943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.